Evacetrapib
CAS: 1186486-62-3
Ref. TM-T6262
2mg | 39.00 € | ||
5mg | 56.00 € | ||
10mg | 96.00 € | ||
25mg | 182.00 € | ||
50mg | 322.00 € | ||
100mg | 553.00 € | ||
1mL*10mM (DMSO) | 80.00 € |
Product Information
- LY2484595
- Cyclohexanecarboxylic acid, 4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-, trans-
- Ly-2484595
- Ly2484595
- trans-4-[[(5S)-5-[[[3,5-Bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]cyclohexanecarboxylic acid
Evacetrapib (LY2484595) inhibits CETP strongly (IC50=5.5 nM), raises HDL cholesterol, no rise in aldosterone/blood pressure. Phase 3.
Chemical properties
Technical inquiry about: TM-T6262 Evacetrapib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.